Swiss reg­u­la­tors in­ves­ti­gate No­var­tis over 'un­law­ful abuse' of der­ma­tol­ogy patent

No­var­tis is be­ing in­ves­ti­gat­ed by an an­titrust watch­dog for as­sert­ing a patent, al­though the com­pa­ny says it stands by its move.

Reg­u­la­tors at the Swiss …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER